Skip to main content

eClinical Solutions Achieves New Medidata Accreditation Enhancing Digital Services to Support High Quality, Faster Digital Trials at Scale

New Medidata Site Cloud: End of Study accreditation helps streamline end of study workflows expanding breadth of technology services available for advancing digital trials

eClinical Solutions, a global provider of digital clinical software and services, today announced its accreditation in Medidata’s Site Cloud: End of Study (EOS) platform. eClinical now holds a total of eight accreditations across the Medidata Clinical Data Cloud and is the first Medidata partner to gain accreditation for the Site Cloud: End of Study product.

eClinical Solutions is a recognized leader in providing advanced clinical data services to the life sciences market with expertise in data acquisition, clinical data management, and statistical analysis and clinical programming. The addition of Medidata’s Site Cloud: End of Study to its portfolio of enabling technologies, including the elluminate Clinical Data Cloud, reflects eClinical Solutions’ wider commitment to delivering best-in-class solutions that accelerate clinical trials, enhance data quality, and enable real-time insights.

Manual end of study processes using physical media and document-based acknowledgement forms create numerous issues and delays in trials, risking file loss, audit failure, and non-compliance. Medidata Site Cloud: EOS simplifies and de-risks end of study exchange by making study files easily accessible through a secure platform.

“With the rapid adoption of decentralized trial models, remote oversight is critical for compliance, and traditional document-centric end of study processes are no longer fit for purpose,” said Grant Williamson, director of data acquisition at eClinical Solutions. “Our clients are asking for faster cycle times and continuous audit-readiness. By incorporating Site Cloud: End of Study into our capabilities, we take advantage of automation capabilities, reduce close-out bottlenecks, and mitigate risks with full visibility across sites.”

As an accredited partner and event sponsor, eClinical will be among the life sciences industry experts speaking at Medidata’s NEXT New York conference in November.

“eClinical has been at the forefront of the Medidata accreditation program since our partnership with them began over ten years ago, and we are eager to hear their insights at our NEXT NY event,” said David Geismar, senior vice president, professional services at Medidata. “The addition of accreditation with Medidata Site Cloud: End of Study further enables eClinical to drive value to sponsors and sites.”

Katrina Rice, chief delivery officer, data services at eClinical Solutions said, “Our team is committed to being the premier data services provider in the clinical services market. Our strategy is to bring together the most powerful technologies available for research—including the elluminate® Clinical Data Cloud and the Medidata Rave Clinical Cloud—with skilled people and optimized processes to deliver an unmatched end user experience for clinical teams. This latest certification is one of the many ways we offer new solutions that deliver immediate value to our client base of more than 100 sponsors across the globe.”

To learn how eClinical Solutions enables life sciences clients to maximize the value of their most critical asset, data, at scale visit: https://www.eclinicalsol.com/contact-us/

About eClinical Solutions

eClinical Solutions helps life sciences organizations around the world accelerate their digital clinical initiatives with modern data infrastructure and analytics. Our intelligent clinical data cloud and data services give our clients real-time, self-service access to all their data from one centralized location; plus, advanced analytics that help them make smarter, faster business decisions. Find out more at eclinicalsol.com.

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.